Agitation In Alzheimer's Disease
Clinical Trial -
Clinics: Barnsley, Blackpool, Cannock, Leeds and Manchester
Therapy Area: Alzheimer’s Disease
Gender and Age: Male or Female aged 50-90 years old
Reimbursement: Reasonable travel expenses such as travel by taxi, may be reimbursed. Food may be provided during long study visits if needed.
About The Research...
With an ageing population, medications to help treat the symptoms of Alzheimer’s disease (AD) become more needed than ever. Statistics show that around 80% of patients show signs of agitation and aggression with an increase in prevalence as the disease progresses. Here at MAC, we understand that the condition is incredibly difficult to deal with.
The study being run at MAC research sites in Barnsley, Blackpool, Cannock, Leeds, Liverpool and Manchester is a Phase III, 16-week study to assess a new medication that could help alleviate symptoms of agitation associated with AD. Over the 16-week period, there’ll be a total of 9 visits to a clinic nearest to you and 2 phone calls from a study doctor. The medication itself is currently known as AVP-786. By participating you may be helping to contribute to the development of a new therapy for agitation in AD that may help improve the quality of life for many people.
A full description of the study will be given at the visit before you decide to participate. At that time, you will also receive the full patient information sheet (PIS).
Key Inclusion Criteria:
- Men and women aged between 50-90
- A diagnosis of Alzheimer’s disease
- Symptoms of agitation associated with Alzheimer’s disease
Key Exclusion Criteria:
- An uncontrolled or unstable medical condition
- Dementia of the non-Alzheimer’s type: vascular, frontotemporal, Parkinson’s etc
Other eligibility criteria will apply. Please contact MAC for more information.
Any other information:
Eligible patients will receive a health screen and study participation will be in collaboration with the patient’s treating physician.
Reasonable travel expenses such as travel by taxi, may be reimbursed. Food may be provided during long study visits if needed.
Key Inclusion Criteria
Key Exclusion Criteria
MAC Clinical Research is currently conducting a trial to test a new potential treatment for agitation in Alzheimer’s disease.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Data Privacy Statement
Data Privacy Statement
The data you share in online forms on this website will be sent to the MAC recruitment team. This data will be used to initially determine which clinical trials may be suitable for you and then to contact you by email and/or telephone. The data will be stored according to the General Data Protection Regulation, which is designed to protect your privacy. The data will be stored on a database for a period consistent with regulatory requirements (which may be in excess of 15 years). Following contact by the MAC recruitment team, if you do not wish to have the data you shared stored on file, the data you have entered into this form will be deleted, along with any data you shared during your contact with the MAC recruitment team. If you wish to proceed with the trial, you will be asked to consent to any further use of your data. If you change your mind and do not want to be contacted, please contact MAC Clinical Research to let them know (Phone: 0800 633 5507; Email: email@example.com) and the data you shared in this form will be deleted.
MAC Research Ltd will do its utmost to protect the privacy of its website visitors. The website processing practices of MAC Research are explained in this policy.
MAC Research will only use information that is relevant to a particular service we offer. For example, registering a name and email address for contact purposes. Other forms may require more information so that we can provide a greater level of service for your request.
Information collected shall only be done so with reasonable purpose, and used in a way that does not invade your privacy. Personal data may be collected for various reasons including for contact purposes, but also to satisfy our own regulatory responsibilities and statutory obligations. We may contact you in relation to providing information to you about new services or requesting feedback.
Should you request at any point to not allow your data to be shared in this way then your service from us will not be affected. By agreeing to share your data you have not forfeited any of your rights as detailed under the General Data Protection Regulation. MAC Research will ensure the same standard of care to safeguard the use of your information and privacy throughout all our services.
Know someone who may be interested in taking part? Share this page here: